Clinical Trials on MDR Tuberculosis in Germany
Total 68 results
-
Research Center BorstelCompletedTuberculosis, Multidrug-resistantGermany
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletedTuberculosis | Drug-resistant TuberculosisGeorgia, Germany, India, Moldova, Republic of, South Africa
-
University of LuebeckUniversity Hospital Tuebingen; University of Giessen; University Hospital Freiburg and other collaboratorsRecruiting
-
Aesculap AGCompletedKidney Cancer | Nephrolithiasis | Prostate Cancer | Nephritis | Kidney Injury | Hydronephrosis | Congenital Abnormality of Kidney | Kidney TuberculosisGermany
-
University Hospital TuebingenRecruiting
-
University of CologneTerminatedPulmonary TuberculosisGermany, Bulgaria, Poland
-
Tuberculosis Network European TrialsgroupUnknownActive Tuberculosis | Monitoring, Immunologic | Tuberculosis in Solid Organ Transplant Recipients | Tuberculosis in Marrow Transplant Recipients | Tuberculosis in Rheumatoid Arthritis | Tuberculosis in Chronic Renal Failure | Tuberculosis in HIV-infected IndividualsDenmark, Germany, Italy, Moldova, Republic of, Norway, Poland, Portugal, Romania, Spain, United Kingdom
-
Research Center BorstelLudwig-Maximilians - University of MunichTerminatedBacterial Infections | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Mycobacterial InfectionGermany, Moldova, Republic of, Romania, Ukraine
-
Vakzine Projekt Management GmbHCompletedHealthy | TuberculosisGermany
-
Michael HoelscherGerman Federal Ministry of Education and Research; German Center for Infection... and other collaboratorsCompletedLung Diseases | Bacterial Infections | Mycobacterium Infections | Tuberculosis | Tuberculosis, PulmonaryGermany
-
Research Center BorstelGerman Cancer Research CenterCompleted
-
BioNTech SERecruiting
-
Prof Gerhard WalzlLondon School of Hygiene and Tropical Medicine; Makerere University; Leiden University... and other collaboratorsCompletedPulmonary TuberculosisUnited Kingdom, Uganda, Ethiopia, Gambia, Germany, Namibia, Netherlands, South Africa
-
University of LeipzigDeutsche Krebshilfe e.V., Bonn (Germany)RecruitingMDS | MDS/MPNGermany, Austria
-
Research Center BorstelAlere Technologies GmbHCompleted
-
Research Center BorstelSiemens Corporate TechnologiesCompleted
-
GWT-TUD GmbHRecruiting
-
DKMS gemeinnützige GmbHActive, not recruiting
-
AstraZenecaCompleted
-
Philipps University Marburg Medical CenterPsychotherapie-Ambulanz Marburg e.V.CompletedCondition: Major Depressive Disorder (MDD)Germany
-
iOMEDICO AGCompleted
-
DKMS gemeinnützige GmbHRecruitingAML | MDS | Peripheral Blood Stem Cell Transplantation | Graft Vs Host Disease | CMML | MDS/MPNGermany
-
Hannover Medical SchoolGenzyme, a Sanofi CompanyUnknownAcute Myeloid Leukemia | MDSGermany
-
University Hospital TuebingenRecruiting
-
GWT-TUD GmbHCompletedMDS and AML Prior to Allogeneic SCTGermany
-
Institut fuer anwendungsorientierte Forschung und...University Medical Center GoettingenCompletedMyelodysplastic Syndromes (MDS) | Chromosmal Aberrations | Karyotype Evolution | Rare Abnormalities | Cytogenetic MonitoringGermany
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium
-
Stichting Hemato-Oncologie voor Volwassenen NederlandSwiss Group for Clinical Cancer ResearchActive, not recruitingAML/MDSNetherlands, Belgium, Germany, Switzerland
-
Goethe UniversityStichting Hemato-Oncologie voor Volwassenen Nederland; Polish Adult Leukemia... and other collaboratorsTerminatedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)Germany, Netherlands
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance)-Conditional ICDsAustralia, Germany, Switzerland, Austria, Singapore
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Tuberculosis Network European TrialsgroupCompletedTuberculosis | Monitoring, ImmunologicDenmark, United Kingdom, Sweden, Australia, Bulgaria, Germany, Greece, Italy, Netherlands, Portugal, Romania, Spain, Switzerland, Turkey
-
Charlotte Niemeyer, MDCompletedMyelodysplastic Syndrome (MDS) | Refractory Cytopenia of Childhood | Hematopoietic Stem Cell Transplantation (SCT) | Reduced Intensity Conditioning (RIC)Germany
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
European Society for Blood and Marrow TransplantationNovartisCompletedMDS | CMMLGermany, Belgium, Czechia
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic Syndrome (MDS)Germany, United Kingdom, France, Netherlands
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)Germany
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
University of UlmSunesis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)Germany
-
GWT-TUD GmbHTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)France, Germany
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)France, Spain, Belgium, Italy, Greece, Hungary, Germany
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
University of UlmTerminated
-
Institut de Recherches Internationales ServierCelgene CorporationActive, not recruitingUntreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic InjuryUnited States, Germany, Netherlands
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Novartis PharmaceuticalsCompleted
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Radboud University Medical CenterRecruitingMyelodysplastic Syndromes (MDS)Denmark, Switzerland, Serbia, Austria, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan